Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Total Equity

Iovance Biotherapeutics Inc Total Equity Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Total Equity from 2010 to 2020.
  • Iovance Biotherapeutics Inc Total Equity for the quarter ending June 06, 2020 was $758m a 53.18% increase of 403m year over year
  • Iovance Biotherapeutics Inc Total Equity for the last 12 months ending June 06, 2020 was $758m a 53.18% increase of 403m year over year
  • Iovance Biotherapeutics Inc Annual Total Equity for 2019 was $299m a -55.93% decrease of -167m from 2018
  • Iovance Biotherapeutics Inc Annual Total Equity for 2018 was $466m a 68.79% increase of 321m from 2017
  • Iovance Biotherapeutics Inc Annual Total Equity for 2017 was $145m a -14.74% decrease of -21m from 2016
Other Balance Sheet Metrics:
  • Iovance Biotherapeutics Inc Total Assets for the quarter ending September 09, 2018 was $271m a 42.63% increase of 115m year over year
  • Iovance Biotherapeutics Inc Other Liabilities for the quarter ending March 03, 2014 was $0m
View Chart On Koyfin

Quarterly IOVA Total Equity Data

06/2020$758m
03/2020$243m
12/2019$299m
09/2019$355m
06/2019$397m
03/2019$435m
12/2018$466m
09/2018$254m
06/2018$271m
03/2018$293m

Annual IOVA Total Equity Data

2019$299m
2018$466m
2017$145m
2016$167m
2015$104m
2014$45m
2013$18m
2012$-11m
2011$-13m
2010$1m